nodes	percent_of_prediction	percent_of_DWPC	metapath
Testolactone—Alopecia—Vismodegib—skin cancer	0.0392	0.0395	CcSEcCtD
Testolactone—Decreased appetite—Vismodegib—skin cancer	0.0274	0.0276	CcSEcCtD
Testolactone—Pain—Vismodegib—skin cancer	0.0269	0.0271	CcSEcCtD
Testolactone—Alopecia—Vemurafenib—skin cancer	0.0242	0.0244	CcSEcCtD
Testolactone—Erythema—Vemurafenib—skin cancer	0.0238	0.024	CcSEcCtD
Testolactone—Alopecia—Imiquimod—skin cancer	0.0206	0.0208	CcSEcCtD
Testolactone—Erythema—Imiquimod—skin cancer	0.0203	0.0205	CcSEcCtD
Testolactone—Vomiting—Vismodegib—skin cancer	0.02	0.0202	CcSEcCtD
Testolactone—Ill-defined disorder—Imiquimod—skin cancer	0.0189	0.019	CcSEcCtD
Testolactone—Nausea—Vismodegib—skin cancer	0.0187	0.0188	CcSEcCtD
Testolactone—Blood pressure increased—Docetaxel—skin cancer	0.0185	0.0187	CcSEcCtD
Testolactone—Malaise—Imiquimod—skin cancer	0.0183	0.0185	CcSEcCtD
Testolactone—Discomfort—Imiquimod—skin cancer	0.0171	0.0172	CcSEcCtD
Testolactone—Decreased appetite—Vemurafenib—skin cancer	0.0169	0.017	CcSEcCtD
Testolactone—Oedema—Imiquimod—skin cancer	0.0166	0.0167	CcSEcCtD
Testolactone—Anorexia—Imiquimod—skin cancer	0.0158	0.0159	CcSEcCtD
Testolactone—Paraesthesia—Imiquimod—skin cancer	0.0149	0.015	CcSEcCtD
Testolactone—Alopecia—Bleomycin—skin cancer	0.0147	0.0148	CcSEcCtD
Testolactone—Erythema—Bleomycin—skin cancer	0.0144	0.0145	CcSEcCtD
Testolactone—Decreased appetite—Imiquimod—skin cancer	0.0144	0.0145	CcSEcCtD
Testolactone—Pain—Imiquimod—skin cancer	0.0142	0.0143	CcSEcCtD
Testolactone—Alopecia—Dactinomycin—skin cancer	0.0137	0.0138	CcSEcCtD
Testolactone—Feeling abnormal—Imiquimod—skin cancer	0.0137	0.0138	CcSEcCtD
Testolactone—Erythema—Dactinomycin—skin cancer	0.0135	0.0136	CcSEcCtD
Testolactone—Ill-defined disorder—Bleomycin—skin cancer	0.0134	0.0135	CcSEcCtD
Testolactone—Malaise—Bleomycin—skin cancer	0.013	0.0131	CcSEcCtD
Testolactone—Ill-defined disorder—Dactinomycin—skin cancer	0.0125	0.0126	CcSEcCtD
Testolactone—Vomiting—Vemurafenib—skin cancer	0.0124	0.0125	CcSEcCtD
Testolactone—Alopecia—Temozolomide—skin cancer	0.0124	0.0125	CcSEcCtD
Testolactone—Erythema—Temozolomide—skin cancer	0.0122	0.0123	CcSEcCtD
Testolactone—Discomfort—Bleomycin—skin cancer	0.0122	0.0122	CcSEcCtD
Testolactone—Malaise—Dactinomycin—skin cancer	0.0122	0.0122	CcSEcCtD
Testolactone—Oedema—Bleomycin—skin cancer	0.0118	0.0119	CcSEcCtD
Testolactone—Nausea—Vemurafenib—skin cancer	0.0116	0.0116	CcSEcCtD
Testolactone—Alopecia—Fluorouracil—skin cancer	0.0114	0.0115	CcSEcCtD
Testolactone—Discomfort—Dactinomycin—skin cancer	0.0113	0.0114	CcSEcCtD
Testolactone—Ill-defined disorder—Temozolomide—skin cancer	0.0113	0.0114	CcSEcCtD
Testolactone—Anorexia—Bleomycin—skin cancer	0.0112	0.0113	CcSEcCtD
Testolactone—Erythema—Fluorouracil—skin cancer	0.0112	0.0113	CcSEcCtD
Testolactone—Oedema—Dactinomycin—skin cancer	0.011	0.0111	CcSEcCtD
Testolactone—Malaise—Temozolomide—skin cancer	0.011	0.0111	CcSEcCtD
Testolactone—Paraesthesia—Bleomycin—skin cancer	0.0106	0.0107	CcSEcCtD
Testolactone—Vomiting—Imiquimod—skin cancer	0.0106	0.0106	CcSEcCtD
Testolactone—Anorexia—Dactinomycin—skin cancer	0.0105	0.0106	CcSEcCtD
Testolactone—Discomfort—Temozolomide—skin cancer	0.0103	0.0103	CcSEcCtD
Testolactone—Decreased appetite—Bleomycin—skin cancer	0.0103	0.0103	CcSEcCtD
Testolactone—Pain—Bleomycin—skin cancer	0.0101	0.0102	CcSEcCtD
Testolactone—Oedema—Temozolomide—skin cancer	0.00995	0.01	CcSEcCtD
Testolactone—Nausea—Imiquimod—skin cancer	0.00986	0.00993	CcSEcCtD
Testolactone—Feeling abnormal—Bleomycin—skin cancer	0.00972	0.00978	CcSEcCtD
Testolactone—Decreased appetite—Dactinomycin—skin cancer	0.00956	0.00963	CcSEcCtD
Testolactone—Anorexia—Temozolomide—skin cancer	0.00948	0.00955	CcSEcCtD
Testolactone—Discomfort—Fluorouracil—skin cancer	0.00945	0.00951	CcSEcCtD
Testolactone—Pain—Dactinomycin—skin cancer	0.0094	0.00947	CcSEcCtD
Testolactone—Oedema—Fluorouracil—skin cancer	0.00916	0.00923	CcSEcCtD
Testolactone—Feeling abnormal—Dactinomycin—skin cancer	0.00906	0.00913	CcSEcCtD
Testolactone—Paraesthesia—Temozolomide—skin cancer	0.00893	0.00899	CcSEcCtD
Testolactone—Anorexia—Fluorouracil—skin cancer	0.00874	0.0088	CcSEcCtD
Testolactone—Decreased appetite—Temozolomide—skin cancer	0.00865	0.00871	CcSEcCtD
Testolactone—Pain—Temozolomide—skin cancer	0.00851	0.00857	CcSEcCtD
Testolactone—Paraesthesia—Fluorouracil—skin cancer	0.00823	0.00829	CcSEcCtD
Testolactone—Alopecia—Docetaxel—skin cancer	0.00823	0.00828	CcSEcCtD
Testolactone—Feeling abnormal—Temozolomide—skin cancer	0.0082	0.00825	CcSEcCtD
Testolactone—Erythema—Docetaxel—skin cancer	0.0081	0.00816	CcSEcCtD
Testolactone—Decreased appetite—Fluorouracil—skin cancer	0.00797	0.00802	CcSEcCtD
Testolactone—Pain—Fluorouracil—skin cancer	0.00784	0.00789	CcSEcCtD
Testolactone—Feeling abnormal—Fluorouracil—skin cancer	0.00755	0.0076	CcSEcCtD
Testolactone—Vomiting—Bleomycin—skin cancer	0.0075	0.00755	CcSEcCtD
Testolactone—Nausea—Bleomycin—skin cancer	0.007	0.00705	CcSEcCtD
Testolactone—Vomiting—Dactinomycin—skin cancer	0.00699	0.00704	CcSEcCtD
Testolactone—Oedema—Docetaxel—skin cancer	0.00661	0.00666	CcSEcCtD
Testolactone—Nausea—Dactinomycin—skin cancer	0.00653	0.00658	CcSEcCtD
Testolactone—Vomiting—Temozolomide—skin cancer	0.00632	0.00637	CcSEcCtD
Testolactone—Anorexia—Docetaxel—skin cancer	0.00631	0.00635	CcSEcCtD
Testolactone—Paraesthesia—Docetaxel—skin cancer	0.00594	0.00598	CcSEcCtD
Testolactone—Nausea—Temozolomide—skin cancer	0.00591	0.00595	CcSEcCtD
Testolactone—Vomiting—Fluorouracil—skin cancer	0.00583	0.00587	CcSEcCtD
Testolactone—Decreased appetite—Docetaxel—skin cancer	0.00575	0.00579	CcSEcCtD
Testolactone—Pain—Docetaxel—skin cancer	0.00566	0.0057	CcSEcCtD
Testolactone—Feeling abnormal—Docetaxel—skin cancer	0.00545	0.00549	CcSEcCtD
Testolactone—Nausea—Fluorouracil—skin cancer	0.00544	0.00548	CcSEcCtD
Testolactone—Vomiting—Docetaxel—skin cancer	0.00421	0.00424	CcSEcCtD
Testolactone—Nausea—Docetaxel—skin cancer	0.00393	0.00396	CcSEcCtD
Testolactone—Drospirenone—PTGS2—skin cancer	0.00257	0.371	CrCbGaD
Testolactone—Triamcinolone—PTGS2—skin cancer	0.0019	0.274	CrCbGaD
Testolactone—Betamethasone—PTGS2—skin cancer	0.00156	0.225	CrCbGaD
Testolactone—Dexamethasone—PTGS2—skin cancer	0.000907	0.131	CrCbGaD
